Thinning hair can feel frustrating and challenging. Our female androgenetic alopecia clinical trials are evaluating an investigational drug to treat AGA in women. By joining a female hair loss study, you can contribute to valuable research and help advance future treatment options for androgenetic alopecia. Learn more about our AGA clinical trials for women in Boston and Needham, and take the next step toward prioritizing your hair health.
Exploring Better Ways to Treat Female Androgenetic Alopecia
Female androgenetic alopecia (FAGA), or female pattern hair loss, is a progressive condition that causes thinning and reduced hair density on the scalp, while often keeping the frontal hairline intact. It is influenced by genetics and increased androgen activity, and is most commonly noticed in postmenopausal women.
Our female androgenetic alopecia clinical trials are working to explore new approaches that may improve hair loss in women. By taking part in a female hair loss study, you can help advance research and support the development of better treatment options. Opportunities to join AGA clinical trials for women are now available in Boston and Needham.
Enroll Now
Tolerability, Efficacy, And Safety Evaluation
Eligibility Criteria
Join the Female Androgenetic Alopecia clinical trials in Boston and help advance research toward a safer, more effective FAGA treatment.
Age Group
18 Years to 65 Years
Gender
Female
Current Status
Recruiting
Total Studies
01
Location
Boston
Frequently Asked Questions
What is Female Androgenetic Alopecia (FAGA)?
Female androgenetic alopecia (FAGA) is a progressive type of hair loss in women.
It causes thinning and reduced hair density on the scalp, usually keeping the frontal hairline intact. FAGA is often influenced by genetics and hormonal (androgen) activity.
Who is affected by FAGA?
It can begin after puberty but is most commonly seen in postmenopausal women and is influenced by genetics and androgen activity.
What is the purpose of the clinical trials?
These trials aim to evaluate a study drug for treating AGA in women.
Who can participate in this female androgenetic alopecia clinical trials?
Women aged 18 to 65 are eligible to take part. The study is currently recruiting participants for the FAGA clinical trial.
Why should I take part?
Participation helps advance scientific understanding, supports future therapies, and may give you access to new treatment possibilities for hair loss.
617-789-5300